Cited by 634Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 139 of the 142 references it cites were found in a registry or an index.

Improving cancer immunotherapy through nanotechnology

Goldberg, Michael S.·2019·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

The 2018 Nobel Prize in Physiology or Medicine was awarded to pioneers in the field of cancer immunotherapy, as the utility of leveraging a patient's coordinated and adaptive immune system to fight the patient's unique tumour has now been validated robustly in the clinic. Still, the proportion of patients who respond to immunotherapy remains modest (~15% objective response rate across indications), as tumours have multiple means of immune evasion. The immune system is spatiotemporally controlled, so therapies that influence the immune system should be spatiotemporally controlled as well, in order to maximize the therapeutic index. Nanoparticles and biomaterials enable one to program the location, pharmacokinetics and co-delivery of immunomodulatory compounds, eliciting responses that cannot be achieved upon administration of such compounds in solution. The convergence of cancer immunotherapy, nanotechnology, bioengineering and drug delivery is opportune, as each of these fields has matured independently to the point that it can now be used to complement the others substantively and rationally, rather than modestly and empirically. As a result, unmet needs increasingly can be addressed with deductive intention. This Review explores how nanotechnology and related approaches are being applied to augmenting both endogenous leukocytes and adoptively transferred ones by informing specificity, influencing localization and improving function.

Integrity signals

Registry

Crossref · 10.1038/s41568-019-0186-9

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448

Show all 142 references

Research works printed but not linked: 2

Luteijn, R. et al. SLC19A1 is a cyclic dinucleotide transporter. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/539767v1 (2019). · DOI
Nature Collection: Nobel Prize in Physiology or Medicine 2018, https://www.nature.com/collections/gqznlfngkz (2018).

Sorted by citations

Items 101–200 of 634

Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation
Pei, M., Xu, R., Zhang, C., Wang, X., Li, C., & Hu, Y. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111378 · Cited by 83
Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs
Dhas, N. L., Kudarha, R. R., Garkal, A., Ghate, V., Sharma, S., Panzade, P. S., Khot, S. V., Chaudhari, P., Singh, A. K., Paryani, M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.015 · Cited by 83
Bionanoparticles in cancer imaging, diagnosis, and treatment
Li, Y., Bao, Q., Yang, S., Yang, M., & Mao, C. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20200027 · Cited by 85
Branched Polymer‐Based Redox/Enzyme‐Activatable Photodynamic Nanoagent to Trigger STING‐Dependent Immune Responses for Enhanced Therapeutic Effect
Luo, Q., Duan, Z., Li, X., Gu, L., Ren, L. F., Zhu, H., Tian, X., Chen, R., Zhang, H., Gong, Q., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202110408 · Cited by 81
Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
Bauleth-Ramos, T., Feijão, T., Gonçalves, A., Shahbazi, M.-A., Liu, Z., Barrias, C., Oliveira, M. J., Granja, P., Santos, H. A., & Sarmento, B. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.025 · Cited by 79
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Han, S., Huang, K., Gu, Z., & Wu, J. (2019) · Nanoscale · doi:10.1039/c9nr08086d · Cited by 85
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
Theivendran, S., Lazarev, S., & Yu, C. (2023) · Exploration · doi:10.1002/exp.20220086 · Cited by 79
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
He, A., Li, X., Dai, Z., Li, Q., Zhang, Y., Ding, M., Wen, Z., Mou, Y., & Dong, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01989-x · Cited by 84
Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma
Wang, C., Shi, X., Song, H., Zhang, C., Wang, X., Huang, P., Dong, A., Zhang, Y., Kong, D., & Wang, W. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120579 · Cited by 77
Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy
Yang, W., Deng, H., Zhu, S., Lau, J., Tian, R., Wang, S., Zhou, Z., Yu, G., Rao, L., He, L., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd1631 · Cited by 76
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives
Lakshmanan, V., Jindal, S., Packirisamy, G., Ojha, S. K., Lian, S., Kaushik, A. K., Alzarooni, A. I. M. A., Metwally, Y. H. H., Thyagarajan, S. P., Jung, Y. D., et al. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00299-4 · Cited by 78
Magnetic systems for cancer immunotherapy
Day, N. B., Wixson, W. C., & Shields, C. W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.023 · Cited by 79
Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy
Hou, G., Chen, Y., Lei, H., Lu, Y., Liu, L., Han, Z., Sun, S., Li, J., & Cheng, L. (2024) · Science Advances · doi:10.1126/sciadv.adp7160 · Cited by 77
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation
Wauters, A. C., Scheerstra, J. F., Vermeijlen, I. G., Hammink, R., Schluck, M., Woythe, L., Wu, H., Albertazzi, L., Figdor, C. G., Tel, J., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c06211 · Cited by 75
Distinct features of iron based metal organic frameworks (MOFs) for ferroptosis mediated cancer therapy: A comprehensive review
Kudarha, R. R., Dhas, N. L., & Mutalik, S. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215330 · Cited by 75
TiO2@ZnO nanocomposites decorated with gold nanoparticles: Synthesis, characterization and their antifungal, antibacterial, anti-inflammatory and anticancer activities
Pragathiswaran, C., Smitha, C., Barabadi, H., Al‐Ansari, M. M., Al-Humaid, L. A., & Saravanan, M. (2020) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2020.108210 · Cited by 74
Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation
Raes, L., Stremersch, S., Fraire, J. C., Brans, T., Goetgeluk, G., Munter, S. D., Hoecke, L. V., Verbeke, R., Hoeck, J. V., Xiong, R., et al. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00523-0 · Cited by 76
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Jia, W., Wu, Y., Xie, Y., Yu, M., & Chen, Y. (2025) · Advanced Materials · doi:10.1002/adma.202413603 · Cited by 77
Nucleic Acid-Based Approaches for Tumor Therapy
Hager, S., Fittler, F. J., Wagner, E., & Bros, M. (2020) · Cells · doi:10.3390/cells9092061 · Cited by 78
Emerging nanomedicines for effective breast cancer immunotherapy
Bahreyni, A., Mohamud, Y., & Luo, H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00741-z · Cited by 73
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
Lee, D., Huntoon, K. M., Wang, Y., Jiang, W., & Kim, B. Y. S. (2021) · Advanced Materials · doi:10.1002/adma.202007576 · Cited by 74
Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
Rinoldi, C., Zargarian, S. S., Nakielski, P., Li, X., Liguori, A., Petronella, F., Presutti, D., Wang, Q., Costantini, M., Sio, L. D., et al. (2021) · Small Methods · doi:10.1002/smtd.202100402 · Cited by 78
Innovation in cancer therapeutics and regulatory perspectives
Sharma, P., Jhawat, V., Mathur, P., & Dutt, R. (2022) · Medical Oncology · doi:10.1007/s12032-022-01677-0 · Cited by 76
Macrophage Membrane-Coated Nano-Gemcitabine Promotes Lymphocyte Infiltration and Synergizes AntiPD-L1 to Restore the Tumoricidal Function
Li, J., Wu, Y., Wang, J., Xu, X., Zhang, A., Li, Y., & Zhang, Z. (2022) · ACS Nano · doi:10.1021/acsnano.2c07861 · Cited by 73
Injectable hydrogels for personalized cancer immunotherapies
Mohaghegh, N., Ahari, A. F., Zehtabi, F., Buttles, C., Davani, S., Hoang, H., Tseng, K., Zamanian, B. B., Khosravi, S., Daniali, A., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.002 · Cited by 72
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Kwon, M., Jung, H., Nam, G., & Kim, I.-S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.009 · Cited by 77
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer
Li, J., Yu, N., Cui, D. M., Huang, J., Luo, Y., & Pu, K. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202305200 · Cited by 73
Nanopharmaceuticals: A focus on their clinical translatability
Bisso, S., & Leroux, J. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119098 · Cited by 73
Advances of Zinc Signaling Studies in Prostate Cancer
Li, D., Stovall, D. B., Wang, W., & Sui, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020667 · Cited by 71
Targeted Therapy and Personalized Medicine
Saeed, R. F., Awan, U. A., Saeed, S., Mumtaz, S., Akhtar, N., & Aslam, S. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-27156-4_10 · Cited by 72
Nanomaterials for refining tumor microenvironment and enhancing therapy in head and neck squamous cell carcinoma: a review
Zheng, K., Song, R., Li, R. F., Liu, M., Ba, Y., Jiang, W., & Fan, K. (2024) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000046 · Cited by 70
Engineered polysaccharides for controlling innate and adaptive immune responses
Nam, J., Kim, A., Kim, K. H., Moon, J. H., Baig, J., Phoo, M. T., Moon, J. J., & Son, S. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00193-2 · Cited by 76
Therapeutic applications of nanobiotechnology
Dutt, Y., Pandey, R. P., Dutt, M., Gupta, A. A., Vibhuti, A., Vidić, J., Raj, V. S., Chang, C.-M., & Priyadarshini, A. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01909-z · Cited by 71
Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
Buss, C. G., & Bhatia, S. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001569117 · Cited by 68
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Mukherjee, A. G., Wanjari, U. R., Namachivayam, A., Murali, R., Prabakaran, D. S., Ganesan, R., Renu, K., Dey, A., Vellingiri, B., Ramanathan, G., et al. (2022) · Vaccines · doi:10.3390/vaccines10091493 · Cited by 69
Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research—A Review
Marcovici, I., Coricovac, D. E., Pînzaru, I., Macasoi, I. G., Popescu, R., Chioibaş, R., Zupkó, I., & Dehelean, C. A. (2022) · Cancers · doi:10.3390/cancers14071838 · Cited by 66
Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects
Zhang, Q., Hou, D., Wen, X., Xin, M., Li, Z., Wu, L., & Pathak, J. L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100333 · Cited by 66
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Li, Q., Liu, X., Yan, C., Zhao, B., Zhao, Y., Yang, L., Shi, M., Yu, H., Li, X., & Luo, K. (2023) · Small · doi:10.1002/smll.202206211 · Cited by 68
Endogenous Stimuli‐Activatable Nanomedicine for Immune Theranostics for Cancer
Wang, W., Jin, Y., Liu, X., Chen, F., Zheng, X., Liu, T., Yang, Y., & Yu, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100386 · Cited by 66
Interactions between Biomedical Micro‐/Nano‐Motors and the Immune Molecules, Immune Cells, and the Immune System: Challenges and Opportunities
Fu, D., Wang, Z., Tu, Y., & Peng, F. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001788 · Cited by 65
Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy
Zhang, C., & Pu, K. (2020) · Small Structures · doi:10.1002/sstr.202000026 · Cited by 65
The era of gene therapy: From preclinical development to clinical application
Alhakamy, N. A., Curiel, D. T., & Berkland, C. J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.021 · Cited by 66
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Jiang, Y., Jiang, Z., Wang, M., & Ma, L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114034 · Cited by 67
Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy
Xie, W., Chen, B., Wen, H., Xiao, P., Wang, L., Liu, W., Wang, D., & Tang, B. Z. (2022) · ACS Nano · doi:10.1021/acsnano.2c02605 · Cited by 64
Advances in preparation, biomedical, and pharmaceutical applications of chitosan-based gold, silver, and magnetic nanoparticles: A review
Jiang, M., Althomali, R. H., Ansari, S. A., Saleh, E. A. M., Gupta, J., Жахангирович, К. Х., Alsaab, H. O., Alwaily, E. R., Hussien, B. M., Mustafa, Y. F., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126390 · Cited by 64
Oxidative Stress and Apoptotic Responses Elicited by Nostoc-Synthesized Silver Nanoparticles against Different Cancer Cell Lines
Hamida, R. S., Albasher, G. I., & Bin-Meferij, M. M. (2020) · Cancers · doi:10.3390/cancers12082099 · Cited by 65
Non-viral transfection technologies for next-generation therapeutic T cell engineering
Raes, L., Smedt, S. C. D., Raemdonck, K., & Braeckmans, K. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107760 · Cited by 67
Supramolecular Immunotherapy of Cancer Based on the Self‐Assembling Peptide Design
Chang, R., & Yan, X. (2020) · Small Structures · doi:10.1002/sstr.202000068 · Cited by 63
Reprogramming Tumor‐Associated Macrophages via ROS‐Mediated Novel Mechanism of Ultra‐Small Cu 2− x Se Nanoparticles to Enhance Anti‐Tumor Immunity
Zheng, Y., Han, Y., Wang, T., Liu, H., Sun, Q., Hu, S., Chen, J., & Li, Z. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202108971 · Cited by 63
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
Lian, G., Mak, T. S., Yu, X., & Lan, H. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010164 · Cited by 63
Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy
Qiu, W., Su, W., Xu, J., Liang, M., Ma, X., Xue, P., Kang, Y., Sun, Z., & Xu, Z. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201233 · Cited by 66
Promising targets based on pattern recognition receptors for cancer immunotherapy
Bai, L., Li, W., Zheng, W., Xu, D., Chen, N., & Cui, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105017 · Cited by 67
Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes
Wang, L., Wang, X., Yang, F., Liu, Y., Meng, L., Pang, Y., Zhang, M., Chen, F., Pan, C., Lin, S., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101280 · Cited by 62
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Zheng, C., Zhang, J., Chan, H. F., Hu, H., Lv, S., Na, N., Tao, Y., & Li, M. (2021) · Small Methods · doi:10.1002/smtd.202001191 · Cited by 61
Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics
Khan, M. A., Singh, D., Ahmad, A., & Siddique, H. R. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105892 · Cited by 62
In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation
Li, S., Chen, H., Liu, H., Liu, L., Yuan, Y., Mao, C., Zhang, W., Zhang, X., Guo, W., Lee, C.-S., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05885 · Cited by 60
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
Mpekris, F., Voutouri, C., Panagi, M., Baish, J. W., Jain, R. K., & Stylianopoulos, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.008 · Cited by 60
Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Lan, Y., Li, X., Liu, B., Lu, J., Zuo, B., Wang, Y., Cao, S., Fu, X., Qu, Y., Luo, X., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101122 · Cited by 62
Beyond PEGylation: nanoparticle surface modulation for enhanced cancer therapy
Taghavimandi, F., Kim, M. G., Lee, M., & Shin, K. (2025) · Health Nanotechnology · doi:10.1186/s44301-025-00014-4 · Cited by 60
Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task
Ni, G., Zhang, L., Yang, X., Li, H., Ma, B., Walton, S. F., Wu, X., Yuan, J., Wang, T., & Liu, X. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1717185 · Cited by 59
Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling
Issinger, O., & Guerra, B. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111650 · Cited by 59
Synthesis of DNA Origami Scaffolds: Current and Emerging Strategies
Bush, J., Singh, S., Vargas, M., Oktay, E., Hu, C.-H., & Veneziano, R. (2020) · Molecules · doi:10.3390/molecules25153386 · Cited by 65
Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy
Tang, Z., Xiao, Y., Kong, N., Chuang, L. I. U., Chen, W., Huang, X., Xu, D., Ouyang, J., Feng, C., Wang, C., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.004 · Cited by 58
Emerging small molecule-engineered hybrid nanomedicines for cancer therapy
Chen, Y., Zhao, T., Bai, M., Gu, T., Sun, J., He, Z., Zhang, S., & Luo, C. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135160 · Cited by 57
Mitochondria-Inspired Nanoparticles with Microenvironment-Adapting Capacities for On-Demand Drug Delivery after Ischemic Injury
Lin, Y., Liu, J., Bai, R., Shi, J., Zhu, X., Liu, J., Guo, J. R., Zhang, W., Liu, H., & Liu, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c04727 · Cited by 56
Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Zuo, S., Song, J., Zhang, J., He, Z., Sun, B., & Sun, J. (2021) · Theranostics · doi:10.7150/thno.59953 · Cited by 56
Functional bioinspired nanocomposites for anticancer activity with generation of reactive oxygen species
Khalid, A. D., Ur-Rehman, N., Tariq, G. H., Ullah, S., Buzdar, S. A., Iqbal, S. S., Sher, E. K., Alsaiari, N. S., Hickman, G. J., & Sher, F. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136885 · Cited by 56
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents
Singh, T., Hassanabad, M. F., & Hassanabad, A. F. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188636 · Cited by 54
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Yu, M., Yang, W., Yue, W., & Chen, Y. (2022) · Advanced Science · doi:10.1002/advs.202204335 · Cited by 54
Bacteria-based bioactive materials for cancer imaging and therapy
Chen, Y., Li, Z.-H., Zeng, X., & Zhang, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114696 · Cited by 54
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
Zhou, X., Qu, M., Tebon, P. J., Jiang, X., Wang, C., Xue, Y., Zhu, J., Zhang, S., Öklü, R., Sengupta, S., et al. (2020) · Advanced Science · doi:10.1002/advs.202001447 · Cited by 55
Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance
Muraoka, D., Harada, N., Shiku, H., & Akiyoshi, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.004 · Cited by 54
Melanin-Based Immunoregulatory Nanohybrids Enhance Antitumor Immune Responses in Breast Cancer Mouse Model
Guo, K., Jiao, Z., Zhao, X., Hu, Y., Zhao, N., & Xu, F. (2023) · ACS Nano · doi:10.1021/acsnano.3c02287 · Cited by 53
Near‐infrared laser‐activated aggregation‐induced emission nanoparticles boost tumor carbonyl stress and immunotherapy of breast cancer
You, P., Suo, M., Huang, Q., Lyu, M., Jiang, Y. H., Wang, S., Tang, W., Ning, S., & Zhang, T. (2023) · Aggregate · doi:10.1002/agt2.432 · Cited by 53
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Tang, Y., Liu, B., Zhang, Y., Liu, Y., Huang, Y., & Fan, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115304 · Cited by 53
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation
Zaccariotto, G. D. C., Bistaffa, M. J., Zapata, A. M. M., Rodero, C. F., Coelho, F. M., Quitiba, J. V. B., de Lima, L. L. P., Sterman, R. G., Cardoso, V. M. D. O., & Zucolotto, V. (2025) · ACS Nano · doi:10.1021/acsnano.4c15765 · Cited by 54
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
Puccini, A., Battaglin, F., Iaia, M. L., Lenz, H., & Salem, M. E. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000404 · Cited by 53
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
Zhang, B., Wu, J., Li, W., Hu, H., Zhao, L., He, P., Zhao, Y., & Li, Y. (2022) · Nano Research · doi:10.1007/s12274-022-4282-x · Cited by 54
Nano‐biotechnology in tumour and cancerous disease: A perspective review
Soni, A., Bhandari, M. P., Tripathi, G. K., Bundela, P., Khiriya, P. K., Khare, P. S., Kashyap, M. K., Dey, A., Vellingiri, B., Suresh, S., et al. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17677 · Cited by 53
In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy
Zhou, H., He, H., Liang, R., Pan, H., Chen, Z., Deng, G., Zhang, S., Ma, Y., Liu, L., & Cai, L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120670 · Cited by 52
Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver
Shen, S., Dai, H., Fei, Z., Chai, Y., Hao, Y., Fan, Q., Dong, Z., Zhu, Y., Xu, J., Ma, Q., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c02391 · Cited by 52
Why Have Nanotechnologies Been Underutilized in The Global Uprising Against The Coronavirus Pandemic?
Uskoković, V. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0163 · Cited by 52
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Dang, B.-T. N., Kwon, T. K., Lee, S., Jeong, J., & Yook, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.007 · Cited by 51
Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer
Zhang, Y., Yang, H., Zhao, J., Wan, P., Hu, Y., Lv, K., Hu, Y., Yang, X., & Ma, M. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001364 · Cited by 50
Tuning the immune system by nanoparticle–biomolecular corona
Palmieri, V., & Caracciolo, G. (2022) · Nanoscale Advances · doi:10.1039/d2na00290f · Cited by 51
Dual stimuli-responsive gelatin-based hydrogel for pH and temperature-sensitive delivery of curcumin anticancer drug
Mahdian, M., Asrari, S. A., Ahmadi, M., Madrakian, T., Jalal, N. R., Afkhami, A., Moradi, M., & Gholami, L. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104537 · Cited by 50
Ultrasmall Ag2Te Quantum Dots with Rapid Clearance for Amplified Computed Tomography Imaging and Augmented Photonic Tumor Hyperthermia
Dong, L., Li, W., Yu, L., Sun, L., Chen, Y., & Hong, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12948 · Cited by 50
Melanoma and Nanotechnology-Based Treatment
Zeng, H., Li, J. X., Hou, K., Wu, Y., Chen, H., & Zeng, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858185 · Cited by 49
Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy
Ye, Q., Wang, Y., Shen, S., Xu, C., & Wang, J. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002139 · Cited by 50
A Triple‐Kill Strategy for Tumor Eradication Reinforced by Metal‐Phenolic Network Nanopumps
Sang, W., Zhang, Z., Wang, G., Xie, L., Li, J., Li, W., Tian, H., & Dai, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202113168 · Cited by 48
Biocompatible 2D Cu-TCPP Nanosheets Derived from Cu2O Nanocubes as Multifunctional Nanoplatforms for Combined Anticancer Therapy
Gao, L., Song, Y., Zhong, J., Lin, X., Zhou, S., & Zhan, G. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01430 · Cited by 47
Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy
Xu, L., Deng, H., Wu, L., Wang, D., Shi, L., Qian, Q., Huang, X., Zhu, L., Gao, X., Yang, J., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12685 · Cited by 47
Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination
Mohammadzadeh, V., Rahiman, N., Cabral, H., Quader, S., Zirak, M. R., Yazdi, M. E. T., Jaafari, M. R., & Alavizadeh, S. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.049 · Cited by 48
Sono‐Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer
Li, M., Liu, Y., Zhang, Y., Yu, N., & Li, J. (2023) · Advanced Science · doi:10.1002/advs.202305150 · Cited by 47
Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy
Huang, R., Zhou, P., Chen, B., Zhu, Y., Chen, X. S., & Min, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c06233 · Cited by 48
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Wang, Z., & Yang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107150 · Cited by 49
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Yi, W., Hu, S., Qian, X., Yan, W., & Li, Y. (2025) · Exploration · doi:10.1002/exp.20240095 · Cited by 49
Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance
Khot, V. M., Salunkhe, A. B., Pricl, S., Bauer, J., Thorat, N. D., & Townley, H. E. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.016 · Cited by 47
NIR-Responsive Photodynamic Nanosystem Combined with Antitumor Immune Optogenetics Bacteria for Precise Synergetic Therapy
Wu, C., Cui, M., Cai, L., Chen, C., Zhu, X., Wu, Y., Liu, J., Wang, H., & Zhang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c01138 · Cited by 46
A battery-free nanofluidic intracellular delivery patch for internal organs
Yin, D., Wang, P., Hao, Y., Yue, W. W., Jiang, X., Yao, K., Wang, Y., Hang, X., Xiao, A., Zhou, J., et al. (2025) · Nature · doi:10.1038/s41586-025-08943-x · Cited by 48

Authors: Goldberg, M. S.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Goldberg, Michael S.
ORCID: Goldberg, Michael S.
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2019-09-06
Volume: 19
Issue: 10
Pages: 587-602
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-019-0186-9
OpenAlex: W2972159813
Cited by: 628
References: 142
Citations by year: 2026: 44 · 2025: 67 · 2024: 81 · 2023: 98 · 2022: 114 · 2021: 122 · 2020: 92 · 2019: 10
FWCI: 8.06
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: cancer immunotherapy, nanotechnology, nanoparticles, biomaterials, drug delivery, immune evasion, spatiotemporal control, pharmacokinetics, co-delivery, adoptive immunotherapy, tumor targeting, nanomedicine
MeSH terms: Animals, Biocompatible Materials, Humans, Immune System, Immunologic Factors, Immunotherapy, Leukocytes, Neoplasms, Nucleic Acids, T-Lymphocytes, Drug Delivery Systems, Adoptive Transfer, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Improving cancer immunotherapy through nanotechnology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks